St Vincent's University Hospital — Clinical Trial Site

74 Registered trials

38 Currently recruiting

Organisation

St Vincent's University Hospital

Location

Dublin 4, Ireland

Identifier

ORG-100030091

Address

Nutley Lane Donnybrook, Elm Park, D04 YN63, Ireland

Departments

#12: Pulmonology
#141: Respiratory
#40344
2201: Main Centre
3903: Oncology
4806: Medicine
Clinical Research Centre
Consultant Physician
D10-515 : Nephrology
Department of Gastroenterology
Department of Haematology
Department of Medical Oncology
Department of Respiratory Medicine
Dept of Neurology
Dermatology
Elm Park
Gastroenterology
Gynaecological Oncology
Haematology
Hematology
Infectious Disease
Infectious Diseases
Medical Oncologist
Medical Oncology
Medical Oncology Clinic
Medical oncology research department
N/A
NA
Nephrology
Oncology
Respiratory
Respiratory Medicine
Rheumatology
School of Medicine
St Vincent's University Hospital (#1)
Trials Unit

Clinical trials at this site (74)

Search interface

A Study to Learn about the Long-Term Health of Adult Participants from a Previous Study of a New Melanoma Treatment Pending

2024-517729-20-00 Melanoma 4
OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 Cardiovascular Disease 5
STAMPEDE2: A randomised controlled platform trial testing treatments in metastatic hormone sensitive prostate cancer Pending

2025-522145-21-00 Metastatic hormone sensitive prostate cancer 5
Phase 3 Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Platinum Resistant Ovarian Cancer With Cyclin E1 Overexpression Pending

2025-522748-42-00 Ovarian cancer 5
Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis Pending

2025-523400-72-00 Cystic fibrosis 4
A clinical trial studying the effect of Tirzepatide in women living with endometrial cancer Pending

2025-523877-40-00 Endometrial adenocarcinoma 4
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants with Platinum-Resistant (Part A) and Platinum-Sensitive (Part B… Recruiting

2025-522255-25-00 Fallopian Tube Neoplasms 5 2026-05-18
A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-021) Recruiting

2023-508047-40-00 Ovarian cancer 5 2026-04-30
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01) Recruiting

2025-520466-22-00 Advanced Platinum-resistant Epithelial Ovarian Cancer 5 2026-04-29
Visugromab in Cachexia International Trial Recruiting

2025-523533-25-00 Cancer-associated Cachexia 10 2026-03-26
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
A clinical study to assess the efficacy of adjuvant immunotherapy with cemiplimab in patients with surgically removed non-small cell lung ca… Recruiting

2024-519901-36-00 Patients with resected stage II-IIIA non-small cell lun 5 2025-12-17
Phase 2 Study of LAD191 in Adults With Hidradenitis Suppurativa Recruiting

2025-521293-34-00 Moderate-to-severe hidradenitis suppurativa 4 2025-12-09
A Phase III Randomised, Open Label Trial of an Intradermal or Subcutaneous booster dose of MVA-BN Vaccine to Investigate MPXV Immunogenicity… Recruiting

2024-518007-22-00 Prevention of monkeypox (mpox) infection 5 2025-12-05
The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting

2024-518589-29-00 Bronchiectasis 5 2025-08-21
BOLD-100 in Combination with FOLFOX for the Treatment of Advanced Solid Tumours Recruiting

2024-517500-11-00 Colorectal Cancer 7 2025-07-15
A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-022) Recruiting

2023-508015-23-00 Ovarian cancer recurrent 5 2025-04-11
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better than Anti-PD1 Alone in Adult Participants with Resectable Stage 3 or 4… Recruiting

2022-502825-17-00 Melanoma 4 2024-10-07
Study BT8009-230 in Subjects with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) Recruiting

2023-504231-41-01 Locally advanced or metastatic urothelial cancer 10 2024-10-02
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis Recruiting

2023-503699-25-00 Progressive Pulmonary Fibrosis 5 2024-07-15
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis Recruiting

2023-503697-21-01 Idiopathic pulmonary fibrosis 5 2024-06-24
Phase II Study of daTopotamab-derUXtecan (Dato-DXd; DS-1026a) in triple-negative brEast cancer patients with newly Diagnosed or prOgressing … Recruiting

2024-518819-19-00 triple negative breast cancer 4 2023-05-23
Single arm phase 2 trial of neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positiv… Recruiting

2024-516582-36-00 Early stage HER2-positive breast cancer 10 2026-05-01